Price$85.96+0.73 (+0.86%)
2026-03-042026-06-05
News · 26 weeks76-79%
2025-12-142026-06-07
Mix5390d
- Insider37(70%)
- SEC Filings7(13%)
- Other5(9%)
- Earnings2(4%)
- Analyst1(2%)
- Leadership1(2%)
Latest news
25 items- INSIDERSEC Form 3 filed by new insider Mistras Theodora3 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERSVP, Corporate Controller Dahl Andrew M. sold $48,853 worth of shares (568 units at $86.08), decreasing direct ownership by 4% to 15,334 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP,Strategy/Corp Development Bobo Donald E Jr sold $2,000,193 worth of shares (23,145 units at $86.42) (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- SECSEC Form SD filed by Edwards Lifesciences CorporationSD - Edwards Lifesciences Corp (0001099800) (Filer)
- INSIDERCVP, TMTT & Surgical Chopra Daveen sold $126,905 worth of shares (1,500 units at $84.60), decreasing direct ownership by 3% to 44,324 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP, TAVR Lippis Daniel J. exercised 620 shares at a strike of $72.68 and sold $50,307 worth of shares (620 units at $81.14) as part of a pre-agreed trading plan (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP,Strategy/Corp Development Bobo Donald E Jr sold $1,472,678 worth of shares (17,968 units at $81.96), decreasing direct ownership by 30% to 22,798 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCEO Zovighian Bernard J converted options into 47,207 shares, covered exercise/tax liability with 26,198 shares, gifted 26,640 shares, received a gift of 26,640 shares and sold $2,833,013 worth of shares (36,351 units at $77.93) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 99,165 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP,Strategy/Corp Development Bobo Donald E Jr converted options into 13,457 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 22% to 32,766 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP, TMTT & Surgical Chopra Daveen converted options into 13,583 shares and covered exercise/tax liability with 7,538 shares, increasing direct ownership by 15% to 45,824 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP, Chief Financial Officer Ullem Scott B. covered exercise/tax liability with 11,004 shares and converted options into 19,830 shares, increasing direct ownership by 23% to 46,740 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP, JAPAC Markowitz Wayne was granted 5,200 shares, covered exercise/tax liability with 490 shares and sold $47,280 worth of shares (593 units at $79.73), increasing direct ownership by 23% to 21,680 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCEO Zovighian Bernard J was granted 43,800 shares, covered exercise/tax liability with 9,551 shares, gifted 9,711 shares and received a gift of 9,711 shares, increasing direct ownership by 31% to 104,796 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP, TAVR Lippis Daniel J. covered exercise/tax liability with 362 shares, decreasing direct ownership by 0.89% to 40,411 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Loranger Steven R was granted 4,315 shares, increasing direct ownership by 92% to 8,997 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Sequeira Ramona was granted 3,251 shares, increasing direct ownership by 92% to 6,779 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Valeriani Nicholas J was granted 5,127 shares, increasing direct ownership by 6% to 84,423 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Feinberg David T was granted 3,251 shares, increasing direct ownership by 56% to 9,087 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Gallahue Kieran was granted 4,315 shares (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Laviolette Paul A was granted 3,251 shares, increasing direct ownership by 23% to 17,552 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP,Strategy/Corp Development Bobo Donald E Jr was granted 7,850 shares and covered exercise/tax liability with 1,869 shares, increasing direct ownership by 29% to 26,778 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Stone Heisz Leslie was granted 3,251 shares, increasing direct ownership by 11% to 34,199 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP, Chief Financial Officer Ullem Scott B. covered exercise/tax liability with 3,034 shares, decreasing direct ownership by 7% to 37,914 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERDirector Davis Leslie C. was granted 3,251 shares, increasing direct ownership by 49% to 9,834 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
- INSIDERCVP, TAVR Lippis Daniel J. covered exercise/tax liability with 759 shares and was granted 7,850 shares, increasing direct ownership by 21% to 40,773 units (SEC Form 4)4 - Edwards Lifesciences Corp (0001099800) (Issuer)
EW FAQ
6 questionsWhat does Edwards Lifesciences Corporation do?
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty...Where does EW stock trade?
Edwards Lifesciences Corporation (EW) is listed on NYSE.What sector and industry is EW in?
Edwards Lifesciences Corporation operates in the Health Care sector, Industrial Specialties industry.What are analysts saying about EW?
Edwards Lifesciences Corporation has had 8 recent analyst actions on file. The most recent action was from Wolfe Research: Outperform on 2026-04-01.What companies are similar to EW?
Notable peers in the same industry include MDT (Medtronic plc.), BDX (Becton Dickinson and Company), ICUI (ICU Medical Inc.). Compare EW side-by-side with any of them on Quantisnow.How can I track EW on Quantisnow?
Quantisnow aggregates Edwards Lifesciences Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EW to receive live email and push alerts on every new disclosure.